Cachectin/tumour-necrosis-factor production by cancer patients.

No abstract is available for this paper.

• Publication year

  1985

• Venue

  The Lancet

• Publication date

  1985-11-23

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(85)92713-8PMID 2865645
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identity of tumour necrosis factor and the macrophage-secreted factor cachectin

  1985cited by this paper
• Preparations of lymphotoxin induce resistance to their own cytotoxic effect.

  1984cited by this paper
• Inhibition of nonspecific tumoricidal activity by activated macrophages with antiserum against a soluble cytotoxic factor

  1981cited by this paper

• Edinburgh Explorer The anti-cachectic effect of fatty acids

  2018cites this paper
• Elucidating the role of T-box protein family members in influenza-specific T cell immunity

  2017cites this paper
• Energy metabolism and nutritional status in hospitalized patients with lung cancer

  2016cites this paper
• Retraction: Phospholipase D1 Plays a Key Role in TNF-α Signaling

  2013cites this paper
• Mechanisms of cancer cachexia.

  2009cites this paper
• Myeloid-derived suppressor cells in cancer cachexia syndrome: a new explanation for an old problem.

  2008cites this paper
• Phospholipase D1 Plays a Key Role in TNF-α Signaling1

  2008cites this paper
• Phospholipase D1 plays a key role in TNF-alpha signaling.

  2008cites this paper
• This information is current as Signaling α Phospholipase D 1 Plays a Key Role in TNF -

  2008cites this paper
• Experimental Rat Model of Cancer Cachexia in an α-Interferon and Tumor Necrosis Factor γ The Roles of Updated Version

  2006cites this paper
• Nutrition modulation of cachexia/proteolysis.

  2006cites this paper
• Increased Serum Levels of Soluble Receptors for Tumor Necrosis Factor in Cancer Patients1

  2006cites this paper
• Tumour necrosis factor-a (TNF-a) in patients who have asbestosis and develop cancer

  2005cites this paper
• Production of interleukin-1 and tumour necrosis factor in non-Hodgkin's lymphoma patients

  2005cites this paper
• Production of interleukin-1β and tumour necrosis factor-α in patients with benign or malignant ovarian tumours

  2005cites this paper
• Tumour-cell-induced production of tumour necrosis factor by monocytes of gastric cancer patients receiving BCG immunotherapy

  2005cites this paper
• Association of tumour necrosis factor and haemodynamic shock in a newborn undergoing surgery for sacrococcygeal teratoma

  2004cites this paper
• Tumor necrosis factor in benign and malign tissue of the kidney

  2004cites this paper
• Cancer cachexia is regulated by selective targeting of skeletal muscle gene products.

  2004cites this paper
• Serum and cyst fluid levels of interleukin (IL) -6, IL-8 and tumour necrosis factor-alpha in women with endometriomas and benign and malignant cystic ovarian tumours.

  2003cites this paper
• The Role of Tumor Necrosis Factor-α in Muscle Wasting Disorders

  2002cites this paper
• Modulatory role of thymosin-alpha-1 in normal bone-marrow haematopoiesis and its effect on myelosuppression in T-cell lymphoma bearing mice.

  2002cites this paper
• Impact of the inflammatory reaction on intermediary metabolism and nutrition status.

  2002cites this paper
• Mouse erythroblast formation is inhibited by anemia-inducing substance from the plasma of a patient with a malignant neoplasm.

  2001cites this paper
• Increased muscle ubiquitin mRNA levels in gastric cancer patients.

  2001cites this paper
• High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials.

  2001cites this paper
• Pathophysiology of cancer cachexia.

  2000cites this paper
• Tumour growth and nitrogen metabolism in the host (Review).

  1999cites this paper
• n-3 Polyunsaturated Fatty Acids in the Treatment of Pancreatic Cancer Cachexia

  1999cites this paper
• The role of cytokines in cancer cachexia

  1999cites this paper
• Dietary omega‐3 polyunsaturated fatty acids plus vitamin E restore immunodeficiency and prolong survival for severely ill patients with generalized malignancy

  1998cites this paper
• The anti-cachectic effect of fatty acids

  1998cites this paper
• Is TNF really involved in cachexia?

  1997cites this paper
• Serum levels of tumour necrosis factor alpha and other cytokines do not correlate with weight loss and anorexia in cancer patients

  1997cites this paper
• Journey from cachexia to obesity by TNF

  1997cites this paper
• The metabolic basis of cancer cachexia

  1997cites this paper
• Effects of lentinan on abnormal ingestive behaviors induced by tumor necrosis factor.

  1997cites this paper
• Cancer cachexia.

  1997cites this paper
• Nutrition, immunité et maladies infectieuses

  1996cites this paper
• Cytokines in Cancer Cachexia

  1996cites this paper
• Are cytokines possible mediators of cancer cachexia?

  1996cites this paper
• Echinomycin Suppresses the Pyrogenic Effects of Endotoxin and Interleukin- lβ in Human Endothelial Cells and Peripheral Blood Mononuclear Cells

  1996cites this paper
• The influence of biomaterials on inflammatory responses to cardiopulmonary bypass

  1996cites this paper
• Rapid turnover proteins as a prognostic indicator in cancer patients

  1995cites this paper
• Proinflammatory Cytokines and the Host Response to Cancer

  1995cites this paper
• Increased resting energy expenditure and weight loss are related to a systemic inflammatory response in lung cancer patients.

  1995cites this paper
• Anemia-inducing substance from plasma of patients with advanced malignant neoplasms.

  1995cites this paper
• Solid Tümörlü Çocuklarda Tümör Nekrozis Faktör-a ve Taurin Düzeyleri

  1995cites this paper
• Tumour necrosis factor-alpha (TNF-alpha) in patients who have asbestosis and develop cancer.

  1995cites this paper
• Enhanced hepatic amino acid transport in tumor-bearing rats is partially blocked by antibody to tumor necrosis factor.

  1995cites this paper
• Malformin-a1 inhibits the binding of interleukin-1β (il1β) and suppresses the expression of tissue factor in human endothelial cells and monocytes

  1994cites this paper
• Tumor-induced regulation of suppressor macrophage nitric oxide and TNF-alpha production. Role of tumor-derived IL-10, TGF-beta, and prostaglandin E2.

  1994cites this paper
• Malformin-A1 inhibits the binding of interleukin-1 beta (IL1 beta) and suppresses the expression of tissue factor in human endothelial cells and monocytes.

  1994cites this paper
• Modulatory effect of Dalton's lymphoma cells on the production of reactive nitrogen intermediates, interleukin-1 and tumor necrosis factor by murine peritoneal macrophages.

  1994cites this paper
• Tumor necrosis factor: a pleiotropic cytokine and therapeutic target.

  1994cites this paper
• Metabolism of a chylomicron-like emulsion in rats with Walker 256 tumor: influence of a polyunsaturated (n-6) compared with a saturated fatty acid-rich diet.

  1994cites this paper
• Serum levels of tumor necrosis factor in squamous cell carcinoma of the head and neck.

  1994cites this paper
• Cytokine levels in patients with urinary tract cancer.

  1994cites this paper
• Abnormal cytokine serum levels correlate with impaired cellular immune responses after surgery.

  1994cites this paper
• Amrinone suppresses the synthesis of tumor necrosis factor-alpha in human mononuclear cells.

  1994cites this paper
• Biochemical and Morphological Alterations in Xylazine-Induced Pulmonary Edema*,†

  1993cites this paper
• Transforming growth factor‐β1, β2, and β3, urokinase and parathyroid hormone‐related peptide expression in 8701‐BC breast cancer cells and clones

  1993cites this paper
• Die Bedeutung der Endothelzellen bei Hämostase und Fibrinolyse - Endothelial cells in hemostasis and fibrinolysis

  1993cites this paper
• Tumor-induced macrophage tumor necrosis factor-alpha production suppresses autoreactive T cell proliferation.

  1993cites this paper
• Experimental cachexia: effects of MCA sarcoma in the Fischer rat.

  1993cites this paper
• Fibrosarcoma‐induced increase in macrophage tumor necrosis factor α synthesis suppresses T cell responses

  1993cites this paper
• Anti-TNF-alpha antibodies normalized body temperature and enhanced food intake in tumor-bearing rats.

  1993cites this paper
• Pathophysiology of cancer cachexia

  1993cites this paper
• Humoral mediation for cachexia in tumour-bearing rats.

  1993cites this paper
• Characterization of spontaneous immunological regression in histiocytoma .2. Participation of tumor-necrosis-factor.

  1993cites this paper
• In Vivo and In Vitro Erythropoietin Activities in Cultures of a Hepatocellular Carcinoma Cell Line

  1993cites this paper
• Elevated serum cytokines in patients with malignancy and weight-loss.

  1993cites this paper
• Chronic Effects of Interleukin-1β on Fever, Oxygen Consumption and Food Intake in the Rat

  1993cites this paper
• The monocyte tumor necrosis factor-alpha production in patients with acute leukemia in complete remission

  1992cites this paper
• The role of cytokines in cancer cachexia.

  1992cites this paper
• Pathophysiology of cancer: hormonal and metabolic abnormalities.

  1992cites this paper
• Clinical Significance of Tumor Necrosis Factor in Patients with Bronchogenic Carcinoma and Benign Lung Diseases: A Comparative Study

  1992cites this paper
• Tumor necrosis factor-alpha in pediatric HIV-1 infection.

  1992cites this paper
• Protein Calorie Malnutrition and Cancer Therapy

  1992cites this paper
• Cytokines and their role in the pathophysiology of cancer cachexia.

  1992cites this paper
• Tumor necrosis factor-α and anorexia—Cause or effect?

  1991cites this paper
• Nutritional support and cancer cachexia. Evolving concepts of mechanisms and adjunctive therapies.

  1991cites this paper
• Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients.

  1991cites this paper
• Tumor necrosis factor-alpha and anorexia--cause or effect?

  1991cites this paper
• Nutritional support of the surgical oncology patient.

  1991cites this paper
• Phase I trial of intravenously administered endotoxin (Salmonella abortus equi) in cancer patients.

  1991cites this paper
• Tumor Necrosis Factor Production in B Cell Chronic Lymphocytic Leukemia.

  1991cites this paper
• Tumor necrosis factor in familial Mediterranean fever.

  1991cites this paper
• Nutritional support of patients with cancer of the gastrointestinal tract.

  1991cites this paper
• The roles of gamma-interferon and tumor necrosis factor alpha in an experimental rat model of cancer cachexia.

  1991cites this paper
• Hormonal Factors Associated with Weight Loss in Patients with Advanced Breast Cancer

  1991cites this paper
• Production of interleukin-1 beta and tumour necrosis factor-alpha in patients with benign or malignant ovarian tumours.

  1991cites this paper
• Interleukin-4 counteracts pyrogen-induced downregulation of thrombomodulin in cultured human vascular endothelial cells.

  1991cites this paper
• Mechanisms of cancer cachexia.

  1991cites this paper
• The pathogenesis of sepsis.

  1991cites this paper
• Immunolocation of TNF-alpha/cachectin in human melanoma cells: studies on co-cultivated malignant melanoma.

  1991cites this paper
• Tumour necrosis factor-alpha immunodetection in blood monocytes and serum: preliminary findings in weight-losing cancer patients.

  1991cites this paper
• [Lipolysis and lipid oxidation of weight stable patients with malignant tumors of the digestive system].

  1991cites this paper
• Cytokine release from mononuclear cells in patients irradiated for breast cancer.

  1991cites this paper
• The Roles of γ-Interferon and Tumor Necrosis Factor α in an Experimental Rat Model of Cancer Cachexia

  1991cites this paper